Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT02917161
Eligibility Criteria:
Inclusion Criteria:
* Men 45 - 75 years old undergoing RALP
* Patient has biopsy-proven prostate adenocarcinoma
* Localized disease (tumorstage cT1-cT2), assessed by clinical and MRI findings
* Written informed consent
Exclusion Criteria:
* Severe atherosclerosis
* Severe tortuosity or ectasia in the aortic bifurcation or internal iliac arteries
* Tumor stage \> cT2 assessed by clinical and MRI findings
* Allergy to intravenous contrast media
* Contraindication for MRI imaging
* Renal failure (GFR\<60ml/min)
* History of pelvic irradiation or radical pelvic surgery
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
45 Years
Maximum Age:
75 Years
Study:
NCT02917161
Study Brief:
Protocol Section:
NCT02917161